EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Resveratrol attenuates efavirenz-induced hepatic steatosis and hypercholesterolemia in mice by inhibiting pregnane X receptor activation and decreasing inflammation

Xingguo Miao, Hui Ye, Xiaoya Cui, Xiuxiu Guo, Feifei Su

Nutrition Research · 2023

DOI: 10.1016/j.nutres.2023.09.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition Research, 2023. Verfasst von Xingguo Miao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Wenzhou Central Hospital, Zhejiang, 325000, China; Department of Infectious Diseases, the Sixth People's Hospital …. Hauptthemen laut MEDLINE: Hypercholesterolemia, Fatty Liver. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efavirenz (EFV), a widely prescribed antiviral medication, has been implicated in dyslipidemia and can activate the pregnane X receptor (PXR), leading to hepatic steatosis and hypercholesterolemia in mice. Resveratrol (RES) can ameliorate hepatic steatosis and functions as a partial PXR agonist, capable of mitigating PXR expression induced by other PXR agonists. Therefore, we hypothesized that RES could attenuate EFV-induced hepatic steatosis and hypercholesterolemia by downregulating PXR expression and suppressing inflammatory cytokine production. Here, we conducted an in vivo study involving 6-week-old male mice, which were divided into 4 groups for a 7-day intervention: control (carrier solution), EFV (80 mg/kg), RES (50 mg/kg), and RES + EFV groups. Serum and hepatic tissue samples were collected to assess cholesterol and triglyceride concentrations. Hepatic lipid accumulation was evaluated through hematoxylin-eosin and oil red O staining. Polymerase chain reaction and western blot were performed to quantify hepatic inflammatory factors, lipogenic gene, and PXR expression. Our results indicated that hepatic lipid droplet accumulation was reduced in the RES + EFV group compared with the EFV group. Similarly, the expressions of hepatic inflammatory factors were attenuated in the RES + EFV group relative to the EFV group. Furthermore, RES counteracted the upregulation of hepatic lipid-metabolizing enzymes induced by EFV at both the transcriptional and protein levels. Importantly, PXR expression was downregulated in the RES + EFV group compared with the EFV group. Conclusively, our findings suggest that RES effectively mitigates EFV-induced hepatic steatosis and hypercholesterolemia by inhibiting PXR activation and decreasing inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypercholesterolemiaFatty LiverMaleMiceAnimalsPregnane X ReceptorResveratrolInflammationCholesterolAlkynesCyclopropanesBenzoxazines

Stichwörter der Autor:innen

EfavirenzHepatic steatosisInflammationPregnane X receptorResveratrol

Substanzen

Pregnane X ReceptorResveratrolCholesterolefavirenzAlkynesCyclopropanesBenzoxazines

Autor:innen und Institutionen

  • Department of Infectious Diseases, Wenzhou Central Hospital, Zhejiang, 325000, China; Department of Infectious Diseases, the Sixth People's Hospital of Wenzhou, Zhejiang, 325000, China; Institute of Translational Medici…
  • Department of Infectious Diseases, Wenzhou Central Hospital, Zhejiang, 325000, China; Department of Infectious Diseases, the Sixth People's Hospital of Wenzhou, Zhejiang, 325000, China.
  • Department of Infectious Diseases, Wenzhou Central Hospital, Zhejiang, 325000, China; Department of Infectious Diseases, the Sixth People's Hospital of Wenzhou, Zhejiang, 325000, China. Electronic address: feifeisuzs@16…

Zitieren

APA

Miao, X., Ye, H., Cui, X., Guo, X., & Su, F. (2023). Resveratrol attenuates efavirenz-induced hepatic steatosis and hypercholesterolemia in mice by inhibiting pregnane X receptor activation and decreasing inflammation. Nutrition Research. https://doi.org/10.1016/j.nutres.2023.09.006

Vancouver

Miao X, Ye H, Cui X, Guo X, Su F. Resveratrol attenuates efavirenz-induced hepatic steatosis and hypercholesterolemia in mice by inhibiting pregnane X receptor activation and decreasing inflammation. Nutrition Research. 2023. doi:10.1016/j.nutres.2023.09.006

BibTeX
@article{Miao2023,
  author = {Miao, Xingguo and Ye, Hui and Cui, Xiaoya and Guo, Xiuxiu and Su, Feifei},
  title = {Resveratrol attenuates efavirenz-induced hepatic steatosis and hypercholesterolemia in mice by inhibiting pregnane X receptor activation and decreasing inflammation},
  journal = {Nutrition Research},
  year = {2023},
  doi = {10.1016/j.nutres.2023.09.006}
}
Kostenlos starten →